Abstract
Anti-neoplastic drugs have made major advancements in oncology, however they are not without cardiovascular consequences. We present a patient with cutaneous T-cell lymphoma receiving Targretin therapy who presented with accelerated atherosclerosis. His triglyceride level (TG) was greater than 1000 mg/dL, which rapidly improved with discontinuation of Targretin.
| Original language | English (US) |
|---|---|
| Article number | 31 |
| Journal | Cardio-Oncology |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 2020 |
All Science Journal Classification (ASJC) codes
- Oncology
- Cardiology and Cardiovascular Medicine